The directions of mild asthma evolution

O. Vakhno, V. Kupaev, D. Nagatkin, A. Zhestkov (Samara, Russian Federation)

Source: Annual Congress 2012 - Asthma management
Session: Asthma management
Session type: Thematic Poster Session
Number: 3424
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Vakhno, V. Kupaev, D. Nagatkin, A. Zhestkov (Samara, Russian Federation). The directions of mild asthma evolution. Eur Respir J 2012; 40: Suppl. 56, 3424

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evolution from mild to severe asthma; the severe asthma clinic perspective
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019


Refining asthma treatment for mild asthma
Source: Virtual Congress 2020 – Rethinking asthma
Year: 2020


The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions
Source: Eur Respir J, 52 (3) 1800328; 10.1183/13993003.00328-2018
Year: 2018



Severe asthma: the way forward
Source: Eur Respir Mon 2011; 51: 297-308
Year: 2011


The management of mild asthma
Source: Eur Respir J, 57 (4) 2003051; 10.1183/13993003.03051-2020
Year: 2021



Defining the clinical clusters of severe asthma within UBIOPRED
Source: International Congress 2015 – Fingerprinting severe asthma
Year: 2015



Are a degree of asthma therapy related to asthma control impairment?
Source: Eur Respir J 2003; 22: Suppl. 45, 370s
Year: 2003

Distribution of biomarkers in severe asthma and severe uncontrolled asthma
Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research
Year: 2021



The occupational contribution to severe exacerbation of current asthma
Source: Annual Congress 2009 - Environmental factors, susceptibility, asthma and COPD
Year: 2009


Identifying asthma features in severe COPD
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018




The modern approaches to the curing of asphyxia attacks at the patients suffering from bronchial asthma of moderate form of severity
Source: Eur Respir J 2007; 30: Suppl. 51, 580s
Year: 2007

Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives
Source: Eur Respir Rev 2015; 24: 594-601
Year: 2015



The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity
Source: Eur Respir J, 52 (5) 1800694; 10.1183/13993003.00694-2018
Year: 2018



The ERS/EAACI statement on severe exacerbations of asthma, and how to deal with non-allergic severe asthma
Source: International Congress 2019 – Pathophysiology and clinical insights into severe non-allergic asthma
Year: 2019


A novel evaluation of the impact of severe allergic asthma in children: The family perspective
Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma
Year: 2010

Management of difficult-to-treat severe asthma
Source: Eur Respir Mon 2011; 51: 282-296
Year: 2011


How much is too much? The treatment of mild asthma
Source: Eur Respir J 2007; 30: 403-406
Year: 2007


Are severe and moderate exacerbations different entities?
Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
Year: 2021


Improved definition of severe asthma phenotypes
Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop
Year: 2014